Menopause and Your Shoulder & Elbow: What the Science Says

A stiffening shoulder. An elbow that aches with everyday tasks. You might be blaming your desk, your sleep position, or just getting older, but there's a well-studied physiological explanation that not enough women hear about.

As a shoulder and elbow surgeon, one of the most consistent patterns I see in my practice is this: women in their late 40s and 50s begin experiencing joint problems that don't trace back to a specific injury. Frozen shoulder. Rotator cuff pain. Tennis elbow that won't respond to the usual treatments. And in many of these cases, the underlying driver isn't just mechanical, it's hormonal as well.

The orthopedic literature has begun to catch up with what clinicians have observed for years. What researchers now call the Musculoskeletal Syndrome of Menopause is real, it's common, and it's treatable. Here's what the science says.

Why menopause affects your joints: the biology

Most people know estrogen as a reproductive hormone. What's far less discussed is its role throughout the entire musculoskeletal system. Estrogen receptors have been found in bone, cartilage, muscle, tendon, and ligaments, and their activation plays a direct role in keeping these tissues healthy.

When estrogen declines during menopause, the consequences cascade through the body's connective tissues. On the tendon side, research published in the Journal of Applied Physiology demonstrated that estrogen is directly involved in regulating collagen synthesis (the protein that gives tendons their tensile strength and resilience). Women on estrogen replacement therapy showed measurably higher rates of tendon collagen production compared to those without it. A separate review confirmed that estrogen receptors have been identified in tenocytes (tendon cells) in both men and women, but the downstream effects of estrogen withdrawal appear especially pronounced in postmenopausal women.

A study published in BMC Musculoskeletal Disorders examined biopsies of the supraspinatus tendon (the most commonly torn rotator cuff tendon) from postmenopausal women and male controls. Estrogen and progesterone receptors were found at statistically significant levels in the tendon cells of postmenopausal women, with receptor expression declining further with age. Importantly, menopause was associated with a reduction in type I collagen, which is the primary structural protein in tendons and ligaments.

The inflammation side is equally important. Estrogen acts as a systemic anti-inflammatory agent, and its decline allows inflammatory signaling to increase. This effect is not subtle; estrogen affects joint fluid, the lining of joint capsules, and the body's ability to recover from routine mechanical stress.

The shoulder: frozen shoulder and what the data shows

Frozen shoulder (or adhesive capsulitis) is probably the condition I associate most strongly with the menopausal transition in my practice. It begins as a gradual ache that slowly evolves into profound stiffness: difficulty reaching overhead, behind your back, or across your body. Left untreated, it can last anywhere from one to two years.

Three-quarters of frozen shoulder patients are women, and the peak age of onset often coincides with the menopausal transition, typically between 45 and 60. This is not coincidence. The inflammatory cascade triggered by declining estrogen appears to promote the fibrotic thickening of the shoulder joint capsule that defines the condition.

Researchers at Duke analyzed the medical records of nearly 2,000 postmenopausal women between ages 45 and 60. Among women who had received hormone replacement therapy, 4% developed adhesive capsulitis — compared to 7.7% among those who had not. Women not on HRT had approximately twice the odds of developing frozen shoulder. While the study authors note that a larger sample is needed to reach statistical significance, the direction of the finding is consistent and clinically meaningful. This was the first known study to specifically examine HRT and frozen shoulder risk.

This evidence has now spurred a randomized controlled trial currently being designed at UCSF — the FSHRT trial — which will directly test HRT as an adjunct treatment for frozen shoulder in peri- and postmenopausal women. The field is moving.

A note on timing

Frozen shoulder progresses through three stages (freezing, frozen, and thawing) and the freezing stage can last up to nine months. Early evaluation matters enormously. The treatments available in the early stages are meaningfully more effective than those available once the shoulder is fully locked. If your shoulder has been gradually stiffening over weeks or months, that's worth a prompt conversation with a specialist.

The rotator cuff: the hidden connection to bone health

The relationship between menopause and rotator cuff disease goes beyond tendon biology. One of the most striking recent findings involves the link between osteoporosis (which disproportionately affects postmenopausal women) and rotator cuff tears.

A large-scale study using causal inference analysis and genetic co-localization found that individuals with osteoporosis were 1.56 times more likely to experience a rotator cuff tear. The increased risk was especially pronounced among women, with researchers pointing to the decline in estrogen post-menopause as a likely mechanism accelerating both bone deterioration and tendon weakening simultaneously. The findings suggest bone and tendon health are far more biologically interconnected than previously understood.

This has direct implications for surgical planning. Research published in a 2026 study using data from over 268,000 patients found that osteoporosis — prevalent in postmenopausal women — affects postoperative outcomes after rotator cuff repair, including rates of revision surgery and shoulder stiffness. When I evaluate a postmenopausal woman for rotator cuff surgery, bone health is now very much part of that conversation.

There is also active research into whether estrogen supplementation after rotator cuff repair might improve healing. A randomized controlled trial currently underway is testing estradiol patches in postmenopausal women after rotator cuff surgery, based on evidence that estradiol deficiency is associated with higher failure rates and worse functional outcomes after repair.

The elbow: why tennis elbow becomes harder to treat

Lateral epicondylitis (AKA tennis elbow) is a tendinopathy affecting the outer elbow, caused by repetitive gripping and arm motion. While it is common across all age groups, in perimenopausal and postmenopausal women, it becomes both more prevalent and more resistant to standard treatments.

The extensor tendons of the elbow, like the rotator cuff, depend on adequate collagen synthesis and turnover for repair. When estrogen falls, that repair process slows. The same tendon-level estrogen receptor biology that affects the shoulder applies at the elbow. A large epidemiological study in the American Journal of Sports Medicine identified female sex as an independent risk factor for lateral epicondylitis — alongside ipsilateral rotator cuff pathology, which often co-occurs in this population for precisely the same hormonal reasons.

Clinical implication

When a postmenopausal woman presents with lateral epicondylitis that is not responding to conventional physical therapy and activity modification, the underlying hormonal context may be contributing to impaired healing. This is part of the rationale for interest in platelet-rich plasma (PRP) in this population — PRP delivers concentrated growth factors locally, potentially compensating for the reduced systemic hormonal support for tissue repair.

What you can do: evidence-based strategies

The research is clear that this isn't something you simply have to accept. These interventions have real data behind them.

Resistance training

The most impactful single intervention. Stimulates bone remodeling (osteoblast activation), preserves muscle mass, and supports tendon health. Studies consistently show high-intensity resistance training can increase bone density in postmenopausal women. Two sessions per week minimum — upper body work is especially valuable for shoulder health.

Shoulder mobility work

Daily gentle shoulder exercises — pendulum swings, doorway stretches, wall slides — help maintain capsular flexibility and reduce frozen shoulder risk. Ten minutes a day is enough to make a meaningful difference during this hormonal transition.

Protein, calcium, and vitamin D

Adequate protein supports muscle and tendon repair. Calcium and Vitamin D are essential as bone turnover accelerates after menopause. Collagen peptide supplements combined with resistance training have shown additive benefits for musculoskeletal tissue in clinical trials. Discuss dosing with your doctor.

Talk to your gynecologist about HRT

HRT isn't appropriate for everyone, but the Duke data and emerging trial evidence make the musculoskeletal case compelling. The North American Menopause Society supports individualized HRT evaluation. If you haven't had this conversation yet, it's worth having.

When to see a specialist

Shoulder stiffness building over weeks or months, elbow pain with daily tasks that isn't improving, or joint symptoms disrupting your sleep are all worth a prompt evaluation. Earlier intervention leads to faster recovery — and for frozen shoulder in particular, treatment in the freezing stage is substantially more effective than treatment once the shoulder is locked.

In Summary

If you're in your late 40s or 50s and your joints have started feeling different — stiffer, achier, less resilient after activity — this is not imaginary, and it is not simply aging. There is a real, increasingly well-characterized biological explanation, and there are concrete strategies to address it.

The most important thing you can do right now is not wait. Whether that means starting a structured strength training program, having a conversation with your gynecologist about HRT, or seeing someone about a shoulder or elbow that's been bothering you — earlier is almost always better, and the evidence is increasingly on your side.

Call to book an appointment:

646-665-6784

---

About the Author

C. Lucas Myerson, MD – Orthopedic surgeon specializing in shoulder and elbow surgery.

Disclaimer

This article is for educational purposes only. It is not a substitute for medical advice. Always talk to your doctor before starting or changing treatment.

References

1. Musculoskeletal Syndrome of Menopause — Foundational Paper Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024 Oct;27(5):466–472. DOI: 10.1080/13697137.2024.2380363 | PMID: 39077777 PubMed · Full text (Tandfonline)

2. Prevalence of Musculoskeletal Pain During Menopause — 71% Statistic Łabędzka-Gardy M, et al. Musculoskeletal Pain during the Menopausal Transition: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2020 Nov;17(22):8567. PMCID: PMC7710408 PubMed Central

3. Estrogen and Tendon Collagen Synthesis in Postmenopausal Women Hansen M, Kongsgaard M, Holm L, Skovgaard D, Magnusson SP, Qvortrup K, Larsen JO, Aagaard P, Dahl M, Serup A, Frystyk J, Flyvbjerg A, Langberg H, Kjaer M. Effect of estrogen on tendon collagen synthesis, tendon structural characteristics, and biomechanical properties in postmenopausal women. Journal of Applied Physiology. 2009 Apr;106(4):1385–93. DOI: 10.1152/japplphysiol.90935.2008 | PMID: 18927264 PubMed · Full text (APS Journals)

4. Estrogen Receptors in the Supraspinatus Tendon — Histopathology Study [Author group, Università di Torino]. The role of estrogen and progesterone receptors in the rotator cuff disease: a retrospective cohort study. BMC Musculoskeletal Disorders. 2021 Oct;22(1):874. PMCID: PMC8529750 DOI: 10.1186/s12891-021-04778-5 | PMID: 34670550 PubMed · PubMed Central · Full text (BMC)

5. HRT and Frozen Shoulder Risk — Duke University Study (Conference Presentation + Published Pilot)

Conference abstract (2022 NAMS Annual Meeting): Saltzman E, Reinke EK, Wahl EP, Ford AC, Kennedy J, Wittstein J. Is Hormone Replacing Therapy Associated with Reduced Risk of Adhesive Capsulitis in Menopausal Women? A Single Center Analysis. Menopause: The Journal of the North American Menopause Society. 2022;29(12):1467. Published in Orthopaedic Journal of Sports Medicine (2023): DOI: 10.1177/2325967123S00174 SAGE Journals

Published peer-reviewed pilot study (2026): Reinke EK, Ford AC, Wahl E, Kennedy J, Poehlein E, Green CL, Saltzman E, Wittstein JR. A preliminary pilot study to address design issues related to research on potential association of hormone therapy and adhesive capsulitis. Climacteric. 2026 Jan 30:1–6. DOI: 10.1080/13697137.2026.2615391 | PMID: 41614260 PubMed · Full text (Tandfonline)

6. Osteoporosis and Rotator Cuff Tear Risk — Large-Scale Causal Inference Study Liu Y, Zhao R, Huang Z, Li F, Li X, Zhou K, Derwin KA, Zheng X, Cai H, Ma J. Association between osteoporosis and rotator cuff tears: evidence from causal inference and colocalization analyses. Bone Research. 2025 Aug 28;13:75. DOI: 10.1038/s41413-025-00450-z PMCID: PMC12391355 Nature/Bone Research · PubMed Central

7. Osteoporosis and Post-Operative Outcomes After Rotator Cuff Repair [He J, Chen T, Wu C, et al.] The impact of osteoporosis on arthroscopic rotator cuff repair and postoperative tendon-to-bone healing. Frontiers in Surgery. 2025 Oct 24. DOI: 10.3389/fsurg.2025.1683843 PMCID: PMC12592027 PubMed Central